DRSLTR

Correspondence Related to Draft Registration Statement

Amylyx Pharmaceuticals, Inc. Filed 2021-10-20 Acc 0000950123-21-013337

Documents 1

DRSLTR Correspondence Related to Draft Registration Statement , filename1.htm

Around this filing

2021-11-24 DRSLTR Correspondence Related to Draft Registration Statement
2021-10-20 DRSLTR Correspondence Related to Draft Registration Statement
2021-10-20 DRS/A Draft Registration Statement

Link to a passage

External

SEC EDGAR (opens in new tab)